93 related articles for article (PubMed ID: 21078287)
21. A 3D scanning confocal imaging method measures pit volume and captures the role of Rac in osteoclast function.
Goldberg SR; Georgiou J; Glogauer M; Grynpas MD
Bone; 2012 Jul; 51(1):145-52. PubMed ID: 22561898
[TBL] [Abstract][Full Text] [Related]
22. Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
Zhu L; Wei H; Wu Y; Yang S; Xiao L; Zhang J; Peng B
Int J Biochem Cell Biol; 2012 Jul; 44(7):1139-52. PubMed ID: 22521613
[TBL] [Abstract][Full Text] [Related]
23. Chloroform extract of deer antler inhibits osteoclast differentiation and bone resorption.
Li YJ; Kim TH; Kwak HB; Lee ZH; Lee SY; Jhon GJ
J Ethnopharmacol; 2007 Sep; 113(2):191-8. PubMed ID: 17646068
[TBL] [Abstract][Full Text] [Related]
24. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
25. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro].
Xiao XH; Zhou HD; Yuan LQ; Xie H; Liao EY
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2102-6. PubMed ID: 15730627
[TBL] [Abstract][Full Text] [Related]
26. RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts.
Wu X; Pan G; McKenna MA; Zayzafoon M; Xiong WC; McDonald JM
J Bone Miner Res; 2005 Jan; 20(1):107-16. PubMed ID: 15619676
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
Väänänen K
Adv Drug Deliv Rev; 2005 May; 57(7):959-71. PubMed ID: 15876398
[TBL] [Abstract][Full Text] [Related]
28. Mangiferin attenuates osteoclastogenesis, bone resorption, and RANKL-induced activation of NF-κB and ERK.
Ang E; Liu Q; Qi M; Liu HG; Yang X; Chen H; Zheng MH; Xu J
J Cell Biochem; 2011 Jan; 112(1):89-97. PubMed ID: 20683903
[TBL] [Abstract][Full Text] [Related]
29. Passive and active in vitro resorption of calcium and magnesium phosphate cements by osteoclastic cells.
Grossardt C; Ewald A; Grover LM; Barralet JE; Gbureck U
Tissue Eng Part A; 2010 Dec; 16(12):3687-95. PubMed ID: 20673025
[TBL] [Abstract][Full Text] [Related]
30. Effects of alendronate on bone formation and osteoclastic resorption after implantation of beta-tricalcium phosphate.
Tanaka T; Saito M; Chazono M; Kumagae Y; Kikuchi T; Kitasato S; Marumo K
J Biomed Mater Res A; 2010 May; 93(2):469-74. PubMed ID: 19582838
[TBL] [Abstract][Full Text] [Related]
31. Quinoxaline derivative of oleanolic acid inhibits osteoclastic bone resorption and prevents ovariectomy-induced bone loss.
Zhao Y; Huai Y; Jin J; Geng M; Li JX
Menopause; 2011 Jun; 18(6):690-7. PubMed ID: 21228726
[TBL] [Abstract][Full Text] [Related]
32. Ultrastructural evidence in vitro of osteoclast-induced degradation of calcium phosphate ceramic by simultaneous resorption and phagocytosis mechanisms.
Heymann D; Guicheux J; Rousselle AV
Histol Histopathol; 2001 Jan; 16(1):37-44. PubMed ID: 11193210
[TBL] [Abstract][Full Text] [Related]
33. Generation and activity of equine osteoclasts in vitro: effects of the bisphosphonate pamidronate (APD).
Gray AW; Davies ME; Jeffcott LB
Res Vet Sci; 2002 Apr; 72(2):105-13. PubMed ID: 12027590
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of Zn2+ in zinc-containing beta-tricalcium phosphate on resorbing activity of mature osteoclasts.
Yamada Y; Ito A; Kojima H; Sakane M; Miyakawa S; Uemura T; LeGeros RZ
J Biomed Mater Res A; 2008 Feb; 84(2):344-52. PubMed ID: 17618520
[TBL] [Abstract][Full Text] [Related]
35. An osteoclastic protein-tyrosine phosphatase is a potential positive regulator of the c-Src protein-tyrosine kinase activity: a mediator of osteoclast activity.
Lau KH; Wu LW; Sheng MH; Amoui M; Suhr SM; Baylink DJ
J Cell Biochem; 2006 Apr; 97(5):940-55. PubMed ID: 16267838
[TBL] [Abstract][Full Text] [Related]
36. Baicalein inhibits osteoclast differentiation and induces mature osteoclast apoptosis.
Kim MH; Ryu SY; Bae MA; Choi JS; Min YK; Kim SH
Food Chem Toxicol; 2008 Nov; 46(11):3375-82. PubMed ID: 18786594
[TBL] [Abstract][Full Text] [Related]
37. Discovery of a New Class of Cathepsin K Inhibitors in Rhizoma Drynariae as Potential Candidates for the Treatment of Osteoporosis.
Qiu ZC; Dong XL; Dai Y; Xiao GK; Wang XL; Wong KC; Wong MS; Yao XS
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999266
[No Abstract] [Full Text] [Related]
38. Receptor activator of NF-kappaB ligand-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro.
Yamaguchi M; Uchiyama S
Int J Mol Med; 2004 Jul; 14(1):81-5. PubMed ID: 15202020
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
[TBL] [Abstract][Full Text] [Related]
40. SNX10 is required for osteoclast formation and resorption activity.
Zhu CH; Morse LR; Battaglino RA
J Cell Biochem; 2012 May; 113(5):1608-15. PubMed ID: 22174188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
